Intercure (Israel) Today
| INCR Stock | ILS 590.00 5.40 0.92% |
PerformanceModest
| Odds Of DistressLow
|
Intercure is trading at 590.00 as of the 17th of March 2025, a 0.92 percent increase since the beginning of the trading day. The stock's open price was 584.6. Intercure has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
InterCure Ltd. invests in the biomedical, life sciences, and biotechnology sectors in Israel and internationally. InterCure Ltd. was founded in 1994 and is based in Hadera, Israel. INTERCURE LTD is traded on Tel Aviv Stock Exchange in Israel. The company has 45.57 M outstanding shares. More on Intercure
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Intercure Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Intercure's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Intercure or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Alexander Rabinovitch |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Intercure (INCR) is traded on Tel Aviv Stock Exchange in Israel and employs 350 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 551.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intercure's market, we take the total number of its shares issued and multiply it by Intercure's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Intercure operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 45.57 M outstanding shares.
Intercure has accumulated about 3.66 M in cash with 25.02 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Intercure Probability Of Bankruptcy
Ownership AllocationIntercure has a total of 45.57 Million outstanding shares. Intercure secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Intercure Ownership Details
Intercure Risk Profiles
Although Intercure's alpha and beta are two of the key measurements used to evaluate Intercure's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.6 | |||
| Semi Deviation | 2.29 | |||
| Standard Deviation | 4.25 | |||
| Variance | 18.1 |
Intercure Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Intercure without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Intercure Corporate Management
Elected by the shareholders, the Intercure's board of directors comprises two types of representatives: Intercure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intercure. The board's role is to monitor Intercure's management team and ensure that shareholders' interests are well served. Intercure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intercure's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amos Cohen | Chief Officer | Profile | |
| Advocate Ohayon | CoFounder Ltd | Profile | |
| OriMoni Mimon | CoFounder Ltd | Profile | |
| Omri Batzir | Co Controller | Profile | |
| Rami Levy | Chief Canndoc | Profile |
Other Information on Investing in Intercure Stock
Intercure financial ratios help investors to determine whether Intercure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intercure with respect to the benefits of owning Intercure security.